1-3 of 3
Margaret Shipp
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detecting Apoptotic Blocks and Sensitvity to ABT-737 and Conventional Chemotherapy Via BH3 Profiling.

Anthony Letai, MD, PhD, Margaret Shipp, MD, Paola dal Cin, MD, Kunihiko Takeyama, PhD, Jing Deng, PhD
Journal: Blood
Blood (2007) 110 (11): 4523.
https://doi.org/10.1182/blood.V110.11.4523.4523
Published: 2007
Journal Articles

BCL6 Programs Lymphoma Cells for Survival and Differentiation through Distinct Biochemical Mechanisms, Both of Which Can Be Therapeutically Targeted.

Samir Parekh, MD, Jose Polo, MSc, Przemyslaw Juszczynski, MD, PhD, Paola Lev, PhD, Stella Ranuncolo, MD, PhD, Georgio Cattoretti, MD, Rita Shaknovich, MD, Margaret Shipp, MD, Ari Melnick, MD
Journal: Blood
Blood (2006) 108 (11): 225.
https://doi.org/10.1182/blood.V108.11.225.225
Published: 2006
Journal Articles

A Phase II Study of Enzastaurin, a Protein Kinase C-β (PKCβ) Inhibitor, in the Treatment of Relapsed Diffuse Large B-Cell Lymphoma (DLBCL).

Michael Robertson, Brad Kahl, Julie Vose, Sven de Vos, Mary Laughlin, Patrick Flynn, Kendrith Rowland, Jose Cruz, Stuart Goldberg, Christelle Darnstein, Nathan Enas, Donna Neuberg, Kerry Savage, Donald Thornton, Christopher Slapak, Margaret Shipp
Journal: Blood
Blood (2005) 106 (11): 934.
https://doi.org/10.1182/blood.V106.11.934.934
Published: 2005